NASDAQ NMS - GLOBAL MARKET · TECH
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Bio-Techne Corp

Bio-Techne Corp

Life Sciences Tools & Services
$70.83

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is TECH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Bio-Techne Corp
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
1989
Employees
3K
Country
US

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$70.83
Last session
Day high
$70.83
Last session
Day low
$70.83
Last session
Previous close
$70.83
52W high
$70.83
0.00% from high
52W low
$70.83
Market cap
$11B
P/E
75.35×
EPS
$0.9400
Shares out
155.8M
VWAP
$70.83
Last session
Veridion warehouse edge

Warehouse intelligence for TECH.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

TECH insider activity

Bio-Techne Corp

Score
Coverage building
Pressure
Net selling
Filings
37
Buys / sells
10 / 27
Net value
-$10.0M
Insiders
10
Named filers
CC
Crouse Steven C.
Insider
Leadership
HE
Herr Amy E.
Insider
Leadership
BS
Bohnen Shane
Insider
Leadership
Cluster

4 insiders bought in the last 90 days

Net pressure

Net selling: -$10.0M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-042026-06-02Crouse Steven C.Insidersell$49.772166,761$11KSEC Form 4
2026-05-122026-05-08Herr Amy E.Insidersell$48.286,636200$320KSEC Form 4
2026-05-122026-05-08Herr Amy E.Insiderbuy$47.606,6366,836$316KSEC Form 4
2026-05-072026-05-05Bohnen ShaneInsidersell$56.687,0557,249$400KSEC Form 4
2026-05-072026-05-05Bohnen ShaneInsiderbuy$47.608,40014,304$400KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 32 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

TECH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TECH in this window.
Lobbying spend

TECH lobbying filings, year to date.

Registered lobbying filings matched to Bio-Techne Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TECH in this window.
Latest news · TECH
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for TECH.
Options
Sovereign unlock shows live options positioning for TECH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.